Complementing T Regulatory Cells to Combat Hypertension-Reference-Cited by-同舟云学术

Complementing T Regulatory Cells to Combat Hypertension

Published:2018-03-30 Issue:7 Volume:122 Page:911-912
ISSN:0009-7330
Container-title:Circulation Research
language:en
Short-container-title:Circ Res

Author:

Mathis Keisa W.¹

Affiliation:

1. From the Department of Physiology and Anatomy, University of North Texas Health Science Center, Fort Worth.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCRESAHA.118.312860

Reference14 articles.

1. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults [published online ahead of print November 7, 2017].;Whelton P;J Am Coll Cardiol

2. Role of the Immune System in Hypertension

3. Inflammation, Immunity, and Hypertension

4. Deficiency of Complement C3a and C5a Receptors Prevents Angiotensin II–Induced Hypertension via Regulatory T Cells

5. Complement in disease: a defence system turning offensive

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II–Induced Hypertension and Hypertensive End-Organ Damage;Hypertension;2024-01

2. Deficiency of complement C3a and C5a receptors does not prevent angiotensin II–induced hypertension and hypertensive end-organ damage;2023-01-25

3. The role of complement pathway-mediated inflammation and immune regulation in the development of hypertension and related target organ damage;SCIENTIA SINICA Vitae;2022-04-29